Role of lefty in the anti tumor activity of human adult liver stem cells

Oncogene

Volumn 32, Issue 7, 2013, Pages 819-826

  Cavallari, C ^a   Fonsato, V ^a   Herrera, M B ^a   Bruno, S ^b   Tetta, C ^b   Camussi, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Italy and Fresenius Medical Care   (Germany)

Author keywords

adult stem cells; hepatoma; lefty; liver; tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; LEFTY A PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT STEM CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL STRAIN HEPG2; EMBRYONIC STEM CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SCID MOUSE; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH;

ADULT STEM CELLS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; HEP G2 CELLS; HUMANS; JURKAT CELLS; LEFT-RIGHT DETERMINATION FACTORS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; NODAL PROTEIN; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84874109961     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.114     Document Type: Article

References (23)

1. Díez-Torre A, Andrade R, Eguizábal C, López E, Arluzea J, Sili M et al. Reprogramming of melanoma cells by embryonic microenvironments. Int J Dev Biol 2009; 53: 1563-1568.
2. Postovit LM, Margaryan V, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 2008; 105: 4329-4334.
3. Hendrix MJ, Seftor EA, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 2007; 7: 246-255.
4. Postovit LM, Seftor EA, Seftor EB, Hendrix MJ. A three-dimensional model to study the epigenetics effects induced by the microenvironment of human embryonic stem cells. Stem cells 2005; 24: 501-505.
5. Pierce GB, Pantazis CG, Caldwell JE, Wells RS. Specificity of the control of tumor formation by the blastocyst. Cancer Res 1982; 42: 1082-1087.
6. Lee LM, Seftor EA, Borde G, Cornell RA, Hendrix MJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005; 233: 1560-1570.
7. Kulesa P, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci USA 2006; 103: 3752-3757.
8. Podesta AH, Mullins J, Pierce GB, Wells RS. The neurula stage mouse embryo in control of neuroblastoma. Proc Natl Acad Sci USA 1984; 81: 7608-7611.
9. Giuffrida D, Rogers IM, Nagy A, Calogero AE, Brown TJ, Casper RF. Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif 2009; 42: 788-798.
10. Sakuma R, Ohnishi Yi Y, Meno C, Fujii H, Juan H, Takeuchi J et al. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 2002; 7: 401-412.
11. Meno C, Takeuchi J, Sakuma R, Koshiba-Takeuchi K, Ohishi S, Saijoh Y et al. Diffusion of nodal signaling activity in the absence of the feedback inhibitor Lefty2. Dev Cell 2001; 1: 127-138.
12. Meno C, Gritsman K, Ohishi S, Ohfuji Y, Heckscher E, Mochida K et al. Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Mol Cell 1999; 4: 287-298.
13. Dvash T, Sharon N, Yanuka O, Benvenisty N. Molecular analysis of LEFTYexpressing cells in early human embryoid bodies. Stem Cells 2007; 25: 465-472.
14. Abbott DE, Bailey CM, Postovit LM, Seftor EA, Margaryan N, Seftor RE et al. The epigenetic influence of tumor and embryonic microenvironments: how different are they? Cancer Microenviron 2008; 1: 13-21.
15. Tabibzadeh S, Hemmati-Brivanlou A. Lefty at the crossroad of 'stemness' and differentiative events. Stem Cells 2006; 24: 1998-2006.
16. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006; 12: 925-932.
17. Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M et al. Reactivation of embryonic nodal signalling is associated with tumor progression and promotes the growth of prostate cancer cells. The Prostate 2011; 71: 1198-1209.
18. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24: 2840-2850.
19. Costa FF, Seftor A, Bischof JM, Kirschmann DA, Strizzi L, Arndt K et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 2009; 1: 387-398.
20. Barroso-delJesus A, Lucena-Aguilar G, Sanchez L, Ligero G, Gutierrez-Aranda I, Menendez P. The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J 2011; 25: 1479-1508.
21. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010; 14: 1605-1618.
22. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F et al. Mesenchymal stem cell-derived microvescicles protect against acute tubular injury. J Am Soc Nephrol 2008; 20: 1053-1067.
23. Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A et al. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 2002; 28: 25195-25202.